Filing Details

Accession Number:
0001209191-13-016062
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-12 19:27:57
Reporting Period:
2013-03-08
Filing Date:
2013-03-12
Accepted Time:
2013-03-12 19:27:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70318 Tenet Healthcare Corp THC Services-General Medical & Surgical Hospitals, Nec (8062) 952557091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568933 T. Audrey Andrews 1445 Ross Avenue
Suite 1400
Dallas TX 75202
Svp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-08 2,157 $31.72 9,057 No 4 M Direct
Common Stock Acquisiton 2013-03-08 10,000 $22.68 19,057 No 4 M Direct
Common Stock Disposition 2013-03-08 15,157 $43.19 3,900 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2006 February Option (Right to Buy) Disposition 2013-03-08 2,157 $0.00 2,157 $31.72
Common Stock 2008 July Option (Right to Buy) Disposition 2013-03-08 10,000 $0.00 10,000 $22.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-22 No 4 M Direct
0 2018-07-28 No 4 M Direct
Footnotes
  1. All historical share and stock option exercise price data in this Form 4 have been restated to reflect a one-for-four reverse stock split effective as of October 11, 2012.
  2. The shares were sold in open market broker transactions. The reporting person continues to meet the Company's stock ownership guidelines.
  3. The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $43.17 to $43.24. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  4. As previously reported, the options were granted on February 22, 2006 and vested ratably on each of the first, second and third anniversaries of the date of grant.
  5. As previously reported, the options were granted on July 28, 2008 and vested ratably on each of the first, second and third anniversaries of the date of grant.